Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound, R19 technology, applied in the field of sphingosine kinase inhibitors, can solve the problem of not identifying the interaction partner
Inactive Publication Date: 2014-07-23
MERCK PATENT GMBH
View PDF24 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, no intracellular interaction partners of S1P have been identified
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0329] I. Synthesis of Selected Compounds of the Invention
[0330] The following compounds were synthesized and identified. However, it is within the knowledge of those skilled in the art to prepare and identify these compounds in other ways.
[0334] 150 mg (0.44 mmol) of 4-(6-bromopyridin-2-yl) piperazine-1-carboxylic acid tert-butyl ester, 112 mg (0.48 mmol) of 5,5,8,8-tetramethyl-5, 6,7,8-tetrahydronaphthalen-2-ylboronic acid and 202 mg (0.88 mmol) of tripotassium phosphate monohydrate were suspended in 6 ml of ethylene glycol monomethyl ether, degassed several times, and degassed under a nitrogen atmosphere 25 mg (0.04 mmol) of bis(triphenylphosphine)palladium(II) dichloride were added. The reaction mixture was stirred at 80° C. for 16 hours, cooled to room temperature, and 20 ml of water were added. The mixture was ex...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
particle size
aaaaa
aaaaa
wavelength
aaaaa
aaaaa
Login to view more
Abstract
The present invention relates to compounds of formula (I) and their physiologically acceptable salts, derivatives, prodrugs, solvates, tautomers and stereoisomers, including their Mixtures in all proportions, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, M1, M2, M3, M4, Y1, Y2, V, W, n, m and o have the meanings given in claim 1.
Description
technical field [0001] The present invention relates to sphingosine kinase inhibitors and physiologically acceptable salts, derivatives, prodrugs, solvates, tautomers and stereoisomers thereof for use in the treatment of diseases affected by the inhibition of Sph kinase 1, including mixtures in all their proportions. Background of the invention [0002] The object of the present invention was to discover new compounds having valuable properties, in particular those which can be used for the preparation of medicaments. [0003] The present invention relates to compounds and the use of these compounds for the treatment of diseases associated with elevated levels of sphingosine phosphate, and to pharmaceutical compositions comprising these compounds. [0004] In particular, the present invention relates to compounds of formula (I), which preferably inhibit the enzyme sphingosine kinase 1, which regulates sphingosine phosphate levels through the phosphorylation of sphingosine, ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more